Literature DB >> 18452141

A quantitative study of factors affecting in vivo bioluminescence imaging.

Kemi Cui1, Xiaoyin Xu, Hong Zhao, Stephen T C Wong.   

Abstract

In vivo bioluminescence imaging (BLI) has the advantages of high sensitivity and low background. By counting the number of photons emitted from a specimen, BLI can quantify biological events such as tumour growth, gene expression and drug response. The intensities and kinetics of the BL signal are affected by many factors and may confound the quantitative results acquired from consecutive imaging sessions or different specimens. We used three different mouse models of tumours to examine whether anaesthetics, positioning and tumour growth may affect the consistency of the BL signal. The results showed that BLI signal could be affected by different anaesthetics and repetitive positioning. Using the same anaesthetics produced consistent peak times, while other factors were held constant. However, as the tumours grew the peak times shifted and the time course of BL signals had different shapes, depending on the positioning of the mice. The data indicate that a carefully designed BLI experiment is required to generate optimal and consistent results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452141     DOI: 10.1002/bio.1032

Source DB:  PubMed          Journal:  Luminescence        ISSN: 1522-7235            Impact factor:   2.464


  18 in total

Review 1.  Noninvasive biophotonic imaging for studies of infectious disease.

Authors:  Nuria Andreu; Andrea Zelmer; Siouxsie Wiles
Journal:  FEMS Microbiol Rev       Date:  2010-10-19       Impact factor: 16.408

2.  Pharmacokinetic modeling of tumor bioluminescence implicates efflux, and not influx, as the bigger hurdle in cancer drug therapy.

Authors:  Hoon Sim; Kristin Bibee; Samuel Wickline; David Sept
Journal:  Cancer Res       Date:  2010-12-01       Impact factor: 12.701

Review 3.  In vivo bioluminescence for tracking cell fate and function.

Authors:  Patricia E de Almeida; Juliaan R M van Rappard; Joseph C Wu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-10       Impact factor: 4.733

4.  Modified breast cancer model for preclinical immunotherapy studies.

Authors:  Eriko Katsuta; Stephanie C DeMasi; Krista P Terracina; Sarah Spiegel; Giao Q Phan; Harry D Bear; Kazuaki Takabe
Journal:  J Surg Res       Date:  2016-06-08       Impact factor: 2.192

5.  A Real-Time Non-invasive Auto-bioluminescent Urinary Bladder Cancer Xenograft Model.

Authors:  Bincy Anu John; Tingting Xu; Steven Ripp; Hwa-Chain Robert Wang
Journal:  Mol Imaging Biol       Date:  2017-02       Impact factor: 3.488

6.  Murine breast cancer mastectomy model that predicts patient outcomes for drug development.

Authors:  Eriko Katsuta; Omar M Rashid; Kazuaki Takabe
Journal:  J Surg Res       Date:  2017-11       Impact factor: 2.192

7.  In vivo imaging using polymeric nanoparticles stained with near-infrared chemiluminescent and fluorescent squaraine catenane endoperoxide.

Authors:  Jung-Jae Lee; Alexander G White; Douglas R Rice; Bradley D Smith
Journal:  Chem Commun (Camb)       Date:  2013-04-14       Impact factor: 6.222

8.  Use of fiber optic technology to measure the effects of anesthesia on luciferase reaction kinetics.

Authors:  Sabrina Semprini; Christopher D Saunter; Mike Ludwig; John M Girkin; John J Mullins
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-11       Impact factor: 1.232

9.  Timing of imaging after d-luciferin injection affects the longitudinal assessment of tumor growth using in vivo bioluminescence imaging.

Authors:  Yusuke Inoue; Shigeru Kiryu; Makoto Watanabe; Arinobu Tojo; Kuni Ohtomo
Journal:  Int J Biomed Imaging       Date:  2010-07-05

10.  Bioluminescence imaging reveals inhibition of tumor cell proliferation by Alzheimer's amyloid beta protein.

Authors:  Hong Zhao; Jinmin Zhu; Kemi Cui; Xiaoyin Xu; Megan O'Brien; Kelvin K Wong; Santosh Kesari; Weiming Xia; Stephen T C Wong
Journal:  Cancer Cell Int       Date:  2009-06-01       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.